Future Oncology : Impact Factor & More
eISSN: 1744-8301pISSN: 1479-6694
Share this on:
Key Metrics
CiteScore 
4.9
Impact Factor
< 5
SNIP
0.82
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Future Oncology
Future Oncology Journal Specifications
| Overview | |
| Publisher | FUTURE MEDICINE LTD |
| Language | English |
| Frequency | Fortnightly |
| General Details | |
| Language | English |
| Frequency | Fortnightly |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Future Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Future Oncology
Commentary on "matching-adjusted indirect comparison of enzalutamide versus darolutamide doublet in mHSPC".
- 8 Aug 2026
- Future oncology (London, England)
Clinical and genetic risk factors for anthracycline‑induced cardiotoxicity in Chinese early‑stage breast cancer patients: a candidate gene study.
- 4 Aug 2026
- Future oncology (London, England)
Synthetic lethality targets in pancreatic ductal adenocarcinoma: prevalence and limitations of liquid biopsy detection in a minority-serving cancer center.
- 1 Aug 2026
- Future oncology (London, England)
Transportability of tislelizumab trial outcomes from RATIONALE-315, RATIONALE-303, and RATIONALE-312 to the European population in early-stage non-small cell lung cancer (NSCLC), advanced NSCLC and extensive-stage small cell lung cancer (ES-SCLC).
- 1 Aug 2026
- Future oncology (London, England)
Prognostic but not predictive: the clinical implications of androgen receptor expression in breast cancer patients undergoing neoadjuvant chemotherapy.
- 1 Aug 2026
- Future oncology (London, England)
Efficacy analysis of first-line chemoimmunotherapy with or without radiotherapy in stage IVB esophageal squamous cell carcinoma: a real-world study.
- 1 Aug 2026
- Future oncology (London, England)
Commentary on "matching-adjusted indirect comparison of enzalutamide versus darolutamide doublet in mHSPC".
- 8 Aug 2026
- Future oncology (London, England)
Clinical and genetic risk factors for anthracycline‑induced cardiotoxicity in Chinese early‑stage breast cancer patients: a candidate gene study.
- 4 Aug 2026
- Future oncology (London, England)
Synthetic lethality targets in pancreatic ductal adenocarcinoma: prevalence and limitations of liquid biopsy detection in a minority-serving cancer center.
- 1 Aug 2026
- Future oncology (London, England)
Transportability of tislelizumab trial outcomes from RATIONALE-315, RATIONALE-303, and RATIONALE-312 to the European population in early-stage non-small cell lung cancer (NSCLC), advanced NSCLC and extensive-stage small cell lung cancer (ES-SCLC).
- 1 Aug 2026
- Future oncology (London, England)
Prognostic but not predictive: the clinical implications of androgen receptor expression in breast cancer patients undergoing neoadjuvant chemotherapy.
- 1 Aug 2026
- Future oncology (London, England)
Efficacy analysis of first-line chemoimmunotherapy with or without radiotherapy in stage IVB esophageal squamous cell carcinoma: a real-world study.
- 1 Aug 2026
- Future oncology (London, England)
FAQs on Future Oncology
How long has Future Oncology been actively publishing? 
What is the publishing frequency of Future Oncology?
How many articles did Future Oncology publish last year?
What is the eISSN & pISSN for Future Oncology?
What is Citescore for Future Oncology?
What is SNIP score for Future Oncology?
Who is the publisher of Future Oncology?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations